COVID-19
This week's top stories include warnings that malicious actors are looking to infect health systems on a large scale, pushback against Trump's claims that doctors are inflating COVID-19 numbers, and CVS' telemedicine-enabled contact renewal service.
Israel is fostering innovation in life sciences, nanotechnology, material engineering and genomics, according to Anya Eldan, VP of the Startup Division of the Israel Innovation Authority.
This week's top stories include a push for a stronger focus on population health to improve health disparities, a drop in hospital admissions, and Borderlands 3's use of its millions of gamers to help map the human gut microbiome.
Alliance for Better Health CEO Dr. Jacob Reider talks about the data and IT demands of coordinating social determinants of health efforts – and the imperative to serve underserved communities, where effects from the COVID-19 pandemic will be felt for a long time.
Leveraging evidence-based knowledge in a meaningful way can help clinicians at the bedside during situations such as COVID-19, says Dr. Ian Chuang, chief medical officer for Elsevier's EMEALAAP Health business.
Cue Health awarded $481M for coronavirus testing; public hospitals compounding COVID-19 budget risks
This week's top stories include Cue expecting to deliver six million COVID-19 molecular tests by March, while surging costs and revenue loss force hospitals to rely on support from county governments.
Jayyou Choi, COO of QTT, discusses the importance of digital transformation and how technology can improve outcomes.
HealthShare Exchange President and CEO Martin Lupinetti discusses lessons learned about data quality and reaching seniors during the COVID-19 crisis.
This week's top stories include HHS requiring hospitals to report flu data, Americans wanting mental healthcare via telehealth, and Clover Health joining the public market by merging with Social Capital SPAC.
Liz Ashall-Payne, founder and CEO of ORCHA, says COVID-19 has accelerated the adoption of telehealth, but digital therapeutics, diagnostics and remote patient monitoring will play a more significant role moving forward.